Covered recipient · General Payments record
REYCHELLE C MORALES
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family
General Payments · PY2024
$512.94
- Reported across 30 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $512.94 | 30 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $246.34 | 13 |
| Amgen Inc. | $139.48 | 9 |
| Lilly USA, LLC | $44.36 | 3 |
| Daiichi Sankyo Inc. | $19.53 | 1 |
| Exact Sciences Corporation | $17.25 | 1 |
| Lundbeck LLC | $16.31 | 1 |
| DEXCOM, INC. | $15.33 | 1 |
| Kowa Pharmaceuticals America, Inc. | $14.34 | 1 |
By program year
All program years on this page · sorted by year
| Program year | Amount | Records |
|---|---|---|
| PY2024 | $512.94 | 30 |
Payment records · PY2024 (30)
Sorted by paying entity, then date · as published by CMS
Program year 2024
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Amgen Inc. | $21.42 | 06/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117633789 | CMS |
| Amgen Inc. | $9.47 | 07/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117633791 | CMS |
| Amgen Inc. | $3.16 | 07/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117633793 | CMS |
| Amgen Inc. | $23.51 | 08/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117633795 | CMS |
| Amgen Inc. | $11.09 | 09/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117633797 | CMS |
| Amgen Inc. | $10.74 | 10/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117633799 | CMS |
| Amgen Inc. | $23.84 | 11/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117332098 | CMS |
| Amgen Inc. | $25.86 | 12/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117332100 | CMS |
| Amgen Inc. | $10.39 | 12/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117633801 | CMS |
| Daiichi Sankyo Inc. | $19.53 | 10/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1089459268 | CMS |
| Dexcom, Inc. | $15.33 | 07/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153383568 | CMS |
| Exact Sciences Corporation | $17.25 | 06/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114433986 | CMS |
| Kowa Pharmaceuticals America, Inc. | $14.34 | 10/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1113474037 | CMS |
| Lilly USA, LLC | $13.95 | 06/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135857959 | CMS |
| Lilly USA, LLC | $15.63 | 08/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135934218 | CMS |
| Lilly USA, LLC | $14.78 | 10/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135900706 | CMS |
| Lundbeck LLC | $16.31 | 10/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146063725 | CMS |
| Novo Nordisk Inc | $21.67 | 06/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100437371 | CMS |
| Novo Nordisk Inc | $8.27 | 07/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100608038 | CMS |
| Novo Nordisk Inc | $22.72 | 07/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100349384 | CMS |
| Novo Nordisk Inc | $22.58 | 08/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100404997 | CMS |
| Novo Nordisk Inc | $12.79 | 08/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100599019 | CMS |
| Novo Nordisk Inc | $20.70 | 09/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100244347 | CMS |
| Novo Nordisk Inc | $28.01 | 09/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100554453 | CMS |
| Novo Nordisk Inc | $8.21 | 10/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100625502 | CMS |
| Novo Nordisk Inc | $28.30 | 11/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100521041 | CMS |
| Novo Nordisk Inc | $20.70 | 11/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100556673 | CMS |
| Novo Nordisk Inc | $27.98 | 11/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100638940 | CMS |
| Novo Nordisk Inc | $20.84 | 12/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100229256 | CMS |
| Novo Nordisk Inc | $3.57 | 12/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100394776 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2024
- Source files
- Dataset page · Bulk file · PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.